tiprankstipranks
Sanofi: Fexalimab Ph2 data showed lower key biomarker of nerve cell damage
PremiumThe FlySanofi: Fexalimab Ph2 data showed lower key biomarker of nerve cell damage
8d ago
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
PremiumThe Fly
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
10d ago
Vigil Neuroscience announces $40M investment from Sanofi
PremiumThe Fly
Vigil Neuroscience announces $40M investment from Sanofi
10d ago
Innate Pharma announces updated results from SAR443579/IPH6101
PremiumThe FlyInnate Pharma announces updated results from SAR443579/IPH6101
20d ago
Novavax price target raised to $18 from $12 at BofA
PremiumThe Fly
Novavax price target raised to $18 from $12 at BofA
23d ago
Regeneron, Sanofi announce FDA approved Kevzara for treatment of pJIA
PremiumThe Fly
Regeneron, Sanofi announce FDA approved Kevzara for treatment of pJIA
26d ago
Delaware Zantac ruling unlikely material for Sanofi, says BofA
PremiumThe FlyDelaware Zantac ruling unlikely material for Sanofi, says BofA
1M ago
Regeneron, Sanofi report FDA extension of target action date for Dupixent review
PremiumThe Fly
Regeneron, Sanofi report FDA extension of target action date for Dupixent review
1M ago
Regeneron, Sanofi announce CHMP opinion recommending approval of Dupixent
PremiumThe Fly
Regeneron, Sanofi announce CHMP opinion recommending approval of Dupixent
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100